Overall survival in patients with relapsed/refractory high grade B-cell lymphomas treated with gemcitabine, oxaliplatin with or without rituximab

In a recent article Dhanapal et al [1] retrospectively assessed the efficacy and toxicity of gemcitabine and oxaliplatin with or without rituximab (GEMOX ± R) for a variety of aggressive lymphoid d...